Jefferies Financial Group Inc. Acquires 13,664 Shares of Doximity, Inc. $DOCS

Jefferies Financial Group Inc. increased its holdings in Doximity, Inc. (NASDAQ:DOCS) by 276.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,600 shares of the company’s stock after acquiring an additional 13,664 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Doximity were worth $1,141,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of DOCS. GAMMA Investing LLC boosted its stake in Doximity by 5.9% during the second quarter. GAMMA Investing LLC now owns 2,981 shares of the company’s stock worth $183,000 after acquiring an additional 165 shares in the last quarter. Louisiana State Employees Retirement System raised its stake in Doximity by 0.5% during the second quarter. Louisiana State Employees Retirement System now owns 37,600 shares of the company’s stock valued at $2,306,000 after buying an additional 200 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Doximity by 0.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after buying an additional 210 shares during the last quarter. ProShare Advisors LLC boosted its holdings in Doximity by 4.1% in the second quarter. ProShare Advisors LLC now owns 5,920 shares of the company’s stock worth $363,000 after acquiring an additional 232 shares in the last quarter. Finally, Main Management ETF Advisors LLC grew its stake in shares of Doximity by 1.7% in the second quarter. Main Management ETF Advisors LLC now owns 14,660 shares of the company’s stock worth $899,000 after acquiring an additional 240 shares during the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on DOCS shares. Bank of America upgraded Doximity from a “neutral” rating to a “buy” rating and raised their price target for the company from $75.00 to $82.00 in a report on Monday, October 27th. Piper Sandler raised their price objective on shares of Doximity from $65.00 to $69.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. BMO Capital Markets began coverage on shares of Doximity in a report on Thursday, November 13th. They issued a “market perform” rating and a $55.00 target price for the company. Wells Fargo & Company increased their price target on shares of Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a report on Monday, August 4th. Finally, JPMorgan Chase & Co. restated an “underweight” rating and issued a $62.00 price objective on shares of Doximity in a report on Friday, October 10th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $68.22.

Doximity Stock Performance

DOCS opened at $50.99 on Thursday. The company’s 50-day simple moving average is $64.06 and its two-hundred day simple moving average is $61.97. The stock has a market capitalization of $9.60 billion, a P/E ratio of 50.99, a P/E/G ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a 52-week low of $46.04 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. Doximity’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same period last year, the firm earned $0.30 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Research analysts forecast that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction on Friday, October 10th. The shares were sold at an average price of $70.84, for a total transaction of $354,200.00. Following the completion of the sale, the director directly owned 19,839 shares in the company, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total value of $1,500,000.00. Following the transaction, the director directly owned 3,221 shares in the company, valued at $241,575. The trade was a 86.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 32,000 shares of company stock worth $2,339,580. Insiders own 31.30% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.